1,3,4,5-Tetrahydro-2H-1-benzazepin-2-one - CAS 4424-80-0
Catalog: |
BB025549 |
Product Name: |
1,3,4,5-Tetrahydro-2H-1-benzazepin-2-one |
CAS: |
4424-80-0 |
Synonyms: |
1,3,4,5-tetrahydro-1-benzazepin-2-one; 1,3,4,5-tetrahydro-1-benzazepin-2-one |
IUPAC Name: | 1,3,4,5-tetrahydro-1-benzazepin-2-one |
Description: | 1,3,4,5-Tetrahydro-2H-1-benzazepin-2-one (CAS# 4424-80-0) is a compound useful in organic synthesis. |
Molecular Weight: | 161.20 |
Molecular Formula: | C10H11NO |
Canonical SMILES: | C1CC2=CC=CC=C2NC(=O)C1 |
InChI: | InChI=1S/C10H11NO/c12-10-7-3-5-8-4-1-2-6-9(8)11-10/h1-2,4,6H,3,5,7H2,(H,11,12) |
InChI Key: | HRVRAYIYXRVAPR-UHFFFAOYSA-N |
Boiling Point: | 339 °C at 760 mmHg |
Density: | 1.1 g/cm3 |
MDL: | MFCD00024149 |
LogP: | 2.09940 |
GHS Hazard Statement: | H302 (97.5%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P270, P272, P280, P301+P312, P302+P352, P321, P330, P333+P313, P363, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
WO-2020238917-A1 | Tetrahydro-1h-benzazepine compound as potassium channel modulator, preparation method and use thereof | 20190531 |
WO-2020007822-A1 | Bismuth metallic (0) nanoparticles, process of manufacturing and uses thereof | 20180702 |
WO-2019191132-A1 | Drug delivery formulations | 20180327 |
EP-3773730-A1 | Drug delivery formulations | 20180327 |
WO-2019116324-A1 | Triazolobenzazepines as vasopressin v1a receptor antagonists | 20171215 |
PMID | Publication Date | Title | Journal |
16271293 | 20060201 | Synthesis and SAR of highly potent and selective dopamine D(3)-receptor antagonists: Quinolin(di)one and benzazepin(di)one derivatives. herve.geneste@abbott.com | Bioorganic & medicinal chemistry letters |
Complexity: | 179 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 161.084063974 |
Formal Charge: | 0 |
Heavy Atom Count: | 12 |
Hydrogen Bond Acceptor Count: | 1 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 161.084063974 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 29.1 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 1.4 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Carbonyl Compounds
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS